NCT04775017已完成不适用
Delirium in Covid-19: Germany-wide Covid-19 Intensive Register
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,398
- 试验地点
- 1
- 主要终点
- Incidence of delirium
研究概览
简要总结
The global pandemic caused by the SARS-CoV-2 virus is confronting the German health system with a novel pathogen. This means that a timely evaluation of all available results is required. In the field of intensive care in particular, there are significant gaps in knowledge, particularly with regard to delirium. In this respect, this study also serves directly to investigate the pathways of delirium outcome in COVID-19 patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients with SARS-CoV-2 positive Covid-19 disease
- •Age≥18 years
- •Proven by positive PCR tests from nasal/ throat swabs as well as samples from the deep respiratory tract.
- •Period 01.01.2020 to 21.02.2022
排除标准
- 未提供
结局指标
主要结局
Incidence of delirium
时间窗: 01.01.2020 - 21.02.2022
Delirium is measured by validated screening scores.
次要结局
- Inflammatory laboratory parameter 4(01.01.2020 - 21.02.2022)
- Toxic-drug factors(01.01.2020 - 21.02.2022)
- Sociodemographic factors(01.01.2020 - 21.02.2022)
- Breathing hours(01.01.2020 - 21.02.2022)
- Length of intensive care unit stay(01.01.2020 - 21.02.2022)
- Length of hospital stay(01.01.2020 - 31.07.2022)
- Serum albumin(01.01.2020 - 21.02.2022)
- Total protein(01.01.2020 - 21.02.2022)
- Phosphate(01.01.2020 - 21.02.2022)
- Triglyceride(01.01.2020 - 21.02.2022)
- Caloric intake(01.01.2020 - 21.02.2022)
- Respiratory setting(01.01.2020 - 21.02.2022)
- Inflammatory laboratory parameter 1(01.01.2020 - 21.02.2022)
- Inflammatory laboratory parameter 2(01.01.2020 - 21.02.2022)
- Inflammatory laboratory parameter 3(01.01.2020 - 21.02.2022)
- Risk factors for severe COVID-19(01.01.2020 - 21.02.2022)
- Patient characteristics(01.01.2020 - 21.02.2022)
- Blood gas analysis(01.01.2020-31.07.2020)
- Enteral nutrition(01.01.2020-31.07.2020)
- Parenteral nutrition(01.01.2020 - 21.02.2022)
- Adverse events(01.01.2020 - 21.02.2022)
- Post Intensive Care Unit Syndrome (PICS)(01.01.2020 - 21.02.2022)
- In-hospital mortality(01.01.2020 - 21.02.2022)
- Mortality(01.01.2020 - 31.08.2022)
研究者
Claudia Spies
Head of the Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK)
Charite University, Berlin, Germany
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)COVID-19Pneumonia Due to Streptococcus PneumoniaePneumonia Due to Other Specified Infectious OrganismsPneumonia, Organism UnspecifiedPneumonia in Diseases Classified ElsewherePneumonia Due to H. InfluenzaeViral PneumoniaBacterial PneumoniaNCT04952337Hannover Medical School400
Unknown
不适用
Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLHCOVIDNCT04347460Technical University of Munich20
Unknown
不适用
The Covid-19 HEalth caRe wOrkErS (HEROES) StudyMental Health DisorderDepressionCovid-19SARS-CoV-2Stress DisorderAnxietyNCT04352634University of Chile2,000
Unknown
1 期
Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With CancerVaccine ReactionPatients With CancerCOVID-19NCT05273541Beijing 302 Hospital100
已完成
不适用
COVID-19 Severity and Psychiatric MorbidityPsychiatric DisorderCOVID-19NCT05124158Instituto Mexicano del Seguro Social78